topical antibiotics
Showing 1 - 25 of 6,389
Postoperative Hernia Trial in Granollers (Wound irrigation with amoxicillin-clavulanate in saline solution, Wound irrigation
Recruiting
- Postoperative Hernia
- Wound irrigation with amoxicillin-clavulanate in saline solution
- Wound irrigation with a saline solution
-
Granollers, Barcelona, SpainHospital General de Granollers
Aug 19, 2022
Surgical Site Infection, Surgery--Complications, Colorectal Surgery Trial in Granollers (Topical antibiotic prophylaxis)
Recruiting
- Surgical Site Infection
- +4 more
- Topical antibiotic prophylaxis
-
Granollers, Barcelona, SpainFundació Privada Hospital Asil de Granollers
Apr 6, 2022
Surgical Site Infection, Complication of Surgical Procedure Trial in Monterrey (Vancomycin 1000 MG)
Recruiting
- Surgical Site Infection
- Complication of Surgical Procedure
- Vancomycin 1000 MG
-
Monterrey, NL, MexicoHospital Universitario "Dr. José E. González"
May 17, 2022
Chronic Skin Ulcer Trial in Vienna (PRF mixed with amikacin and teicoplanin, PRF mixed with PHMB plus Macrogolol, PRF plus
Recruiting
- Chronic Skin Ulcer
- PRF mixed with amikacin and teicoplanin
- +3 more
-
Vienna, AustriaMedical University of Vienna
Apr 6, 2022
Inflammation; Skin Trial in Leiden (Erythromycin 4% topical gel formulation:, Clindamycin 1% lotion formulation:, Prednisolone
Completed
- Inflammation; Skin
- Erythromycin 4% topical gel formulation:
- +4 more
-
Leiden, Zuid-Holland, NetherlandsCentre for Human Drug Research
Aug 2, 2021
Chronic Rhinosinusitis Trial in Rochester (oral levofloxacin, nebulized levofloxacin)
Completed
- Chronic Rhinosinusitis
- oral levofloxacin
- nebulized levofloxacin
-
Rochester, New YorkUniversity of Rochester Department of Otolaryngology Head and Ne
Mar 2, 2021
Ocular Flora Resistance From Repeated Topical Antibiotic Use
Completed
- Increased Drug Resistance
- Infection Resistant to Quinolones and Fluoroquinolones
-
Toronto, Ontario, CanadaSunnybrook Health and Sciences Centre
Mar 16, 2021
Ophthalmopathy , Lacrimal System Trial in Sohag (5 mg chloramphenicol, 1 mg dexamethasone sodium phosphate, 0.25 mg tetryzoline
Completed
- Ophthalmopathy , Lacrimal System
- 5 mg chloramphenicol, 1 mg dexamethasone sodium phosphate, 0.25 mg tetryzoline hydrochloride, 2 mg Hydroxypropyl Methyl Cellulose, 10 mg α-tocopherol acetate and 8 mg macrogol 400).
- sodium hyaluronate, polyethylene and propylene glycol based) three times daily for three months
-
Sohag, EgyptSohag University
Sep 3, 2021
Intracranial Pathology Trial in Pittsburgh (Antibiotic Irrigation)
Not yet recruiting
- Intracranial Pathology
- Antibiotic Irrigation
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Dec 2, 2022
Topical Insulin in Neurotrophic Keratopathy After Diabetic
Not yet recruiting
- Corneal Ulcer
- +2 more
- rapid acting insulin
-
BaNHA, EgyptBenha University
Jul 2, 2023
Neurotrophic Keratitis Trial in Canada (Insulin, Tarsorrhaphy)
Recruiting
- Neurotrophic Keratitis
- Insulin
- Tarsorrhaphy
-
Edmonton, Alberta, Canada
- +5 more
Feb 2, 2023
Periprosthetic Joint Infection, Draining Wound Trial in Hamilton (Povidone-Iodine Lavage Solution, Chlorhexidine Lavage
Recruiting
- Periprosthetic Joint Infection
- Draining Wound
- Povidone-Iodine Lavage Solution
- +3 more
-
Hamilton, Ontario, Canada
- +3 more
Nov 30, 2022
Antimicrobial Regimens in Microbial Keratitis: A Prospective
Recruiting
- Bacterial Keratitis
- +3 more
- Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution
- +7 more
-
Alexandria, EgyptCornea Outpatient Clinic at Alexandria Main University Hospital
Dec 15, 2022
Myopia Trial in Assiut (Preservative-free Benoxinate HCl 0.4% (Benoxidia unit-dose vials [UD], Orchidia pharmaceutical Ind.,
Completed
- Myopia
- Preservative-free Benoxinate hydrochloride 0.4% (Benoxidia unit-dose vials [UD], Orchidia pharmaceutical Ind., Egypt)
- Preservative-free Sodium hyaluronate 0.2% (Polyfresh unit-dose vials [UD], Orchidia pharmaceutical Ind., Egypt).
-
Assiut, EgyptTiba Eye Center
Feb 8, 2023
Hip Prosthesis Infection Trial in France (Defensive Antiadhesive Coating DAC®, Novagenit SRL)
Recruiting
- Hip Prosthesis Infection
- Defensive Antiadhesive Coating DAC®, Novagenit SRL
-
Amiens, France
- +13 more
Dec 13, 2022
Bacterial Keratitis Trial in Haifa, Ramat Gan (Hyper-CL™ lens)
Completed
- Bacterial Keratitis
- Hyper-CL™ lens
-
Haifa, Israel
- +1 more
Nov 18, 2021
Acne Vulgaris Trial in Taoyuan (topical minoxidil in Acne Vulgaris)
Recruiting
- Acne Vulgaris
- topical minoxidil in Acne Vulgaris
-
Taoyuan, TaiwanLinkou Chang Gung Memorial Hospital
Nov 1, 2023
Periodontitis Trial (Minocycline Topical, Metronidazole Topical Gel)
Unknown status
- Periodontitis
- Minocycline Topical
- Metronidazole Topical Gel
- (no location specified)
Oct 13, 2019
Antibiotic Resistance, Ocular Surface Microbiome, Gut Resistome Trial in San Francisco (Moxifloxacin (Topical))
Recruiting
- Antibiotic Resistance
- +2 more
- Moxifloxacin (Topical)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 2, 2022
Pemphigus Vulgaris, Bullous Pemphigoid Trial in Cairo (Ozonated olive oil, Topical garamycin cream)
Recruiting
- Pemphigus Vulgaris
- Bullous Pemphigoid
- Ozonated olive oil
- Topical garamycin cream
-
Cairo, EgyptDermatology Department, Cairo University Hospitals
Nov 4, 2022
Diabetic Foot Infection, Diabetic Foot Trial in Dallas (Topical Pravibismane, Standard of Care)
Recruiting
- Diabetic Foot Infection
- Diabetic Foot
- Topical Pravibismane
- Standard of Care
-
Dallas, Texas
- +3 more
Jul 7, 2022
Ophthalmopathy Trial in Sohag (sterilization)
Recruiting
- Ophthalmopathy
- sterilization
-
Sohag, Egypt
- +1 more
Oct 22, 2023
Arthroplasty Complications, Periprosthetic Fracture of Hip Trial (Vancomycin)
Not yet recruiting
- Arthroplasty Complications
- Periprosthetic Fracture of Hip
- (no location specified)
Jan 15, 2023
Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain Trial in Cleveland (Dexamethasone Ophthalmic Insert,
Enrolling by invitation
- Vitreoretinal Surgery
- +3 more
- Dexamethasone Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
Feb 24, 2022